FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313236480> ?p ?o ?g. }

• W4313236480 endingPage "130" @default.
• W4313236480 startingPage "130" @default.
• W4313236480 abstract "The clinical utility of polygenic risk scores (PRS) for coronary artery disease (CAD) has not yet been established.To investigate the ability of a CAD PRS to potentially guide statin initiation in primary prevention after accounting for age and clinical risk.This was a longitudinal cohort study with enrollment starting on January 1, 2006, and ending on December 31, 2010, with data updated to mid-2021, using data from the UK Biobank, a long-term population study of UK citizens. A replication analysis was performed in Biobank Japan. The analysis included all patients without a history of CAD and who were not taking lipid-lowering therapy. Data were analyzed from January 1 to June 30, 2022.Polygenic risk for CAD was defined as low (bottom 20%), intermediate, and high (top 20%) using a CAD PRS including 241 genome-wide significant single-nucleotide variations (SNVs). The pooled cohort equations were used to estimate 10-year atherosclerotic cardiovascular disease (ASCVD) risk and classify individuals as low (<5%), borderline (5-<7.5%), intermediate (7.5-<20%), or high risk (≥20%).Myocardial infarction (MI) and ASCVD events (defined as incident clinical CAD [including MI], stroke, or CV death).A total of 330 201 patients (median [IQR] age, 57 [40-74] years; 189 107 female individuals [57%]) were included from the UK Biobank. Over the 10-year follow-up, 4454 individuals had an MI. The CAD PRS was significantly associated with the risk of MI in all age groups but had significantly stronger risk prediction at younger ages (age <50 years: hazard ratio [HR] per 1 SD of PRS, 1.72; 95% CI, 1.56-1.89; age 50-60 years: HR, 1.46; 95% CI, 1.38-1.53; age >60 years: HR, 1.42; 95% CI, 1.37-1.48; P for interaction <.001). In patients younger than 50 years, those with high PRS had a 3- to 4-fold increased associated risk of MI compared with those in the low PRS category. A significant interaction between CAD PRS and age was replicated in Biobank Japan. When CAD PRS testing was added to the clinical ASCVD risk score in individuals younger than 50 years, 591 of 4373 patients (20%) with borderline risk were risk stratified into intermediate risk, warranting initiation of statin therapy and 3198 of 7477 patients (20%) with both borderline or intermediate risk were stratified as low risk, thus not warranting therapy.Results of this cohort study suggest that the predictive ability of a CAD PRS was greater in younger individuals and can be used to better identify patients with borderline and intermediate clinical risk who should initiate statin therapy." @default.
• W4313236480 created "2023-01-06" @default.
• W4313236480 creator A5005968538 @default.
• W4313236480 creator A5010690225 @default.
• W4313236480 creator A5014525847 @default.
• W4313236480 creator A5016322021 @default.
• W4313236480 creator A5025895448 @default.
• W4313236480 creator A5026570229 @default.
• W4313236480 creator A5030057930 @default.
• W4313236480 creator A5033755499 @default.
• W4313236480 creator A5038231164 @default.
• W4313236480 creator A5043295370 @default.
• W4313236480 creator A5057781163 @default.
• W4313236480 creator A5069822855 @default.
• W4313236480 creator A5081787271 @default.
• W4313236480 creator A5091367654 @default.
• W4313236480 creator A5091546966 @default.
• W4313236480 creator A5091904917 @default.
• W4313236480 date "2023-02-01" @default.
• W4313236480 modified "2023-10-18" @default.
• W4313236480 title "Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention" @default.
• W4313236480 cites W2047717955 @default.
• W4313236480 cites W2153483268 @default.
• W4313236480 cites W2171705978 @default.
• W4313236480 cites W2238851414 @default.
• W4313236480 cites W2299533639 @default.
• W4313236480 cites W2549881333 @default.
• W4313236480 cites W2586504828 @default.
• W4313236480 cites W2587257410 @default.
• W4313236480 cites W2746902023 @default.
• W4313236480 cites W2988296254 @default.
• W4313236480 cites W3001764054 @default.
• W4313236480 cites W3007698544 @default.
• W4313236480 cites W3008788084 @default.
• W4313236480 cites W3028713471 @default.
• W4313236480 cites W3087064672 @default.
• W4313236480 cites W3099022840 @default.
• W4313236480 cites W3120024143 @default.
• W4313236480 cites W3121264076 @default.
• W4313236480 cites W3194537521 @default.
• W4313236480 cites W3206063371 @default.
• W4313236480 cites W4245618364 @default.
• W4313236480 cites W4310766578 @default.
• W4313236480 doi "https://doi.org/10.1001/jamacardio.2022.4466" @default.
• W4313236480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36576811" @default.
• W4313236480 hasPublicationYear "2023" @default.
• W4313236480 type Work @default.
• W4313236480 citedByCount "10" @default.
• W4313236480 countsByYear W43132364802023 @default.
• W4313236480 crossrefType "journal-article" @default.
• W4313236480 hasAuthorship W4313236480A5005968538 @default.
• W4313236480 hasAuthorship W4313236480A5010690225 @default.
• W4313236480 hasAuthorship W4313236480A5014525847 @default.
• W4313236480 hasAuthorship W4313236480A5016322021 @default.
• W4313236480 hasAuthorship W4313236480A5025895448 @default.
• W4313236480 hasAuthorship W4313236480A5026570229 @default.
• W4313236480 hasAuthorship W4313236480A5030057930 @default.
• W4313236480 hasAuthorship W4313236480A5033755499 @default.
• W4313236480 hasAuthorship W4313236480A5038231164 @default.
• W4313236480 hasAuthorship W4313236480A5043295370 @default.
• W4313236480 hasAuthorship W4313236480A5057781163 @default.
• W4313236480 hasAuthorship W4313236480A5069822855 @default.
• W4313236480 hasAuthorship W4313236480A5081787271 @default.
• W4313236480 hasAuthorship W4313236480A5091367654 @default.
• W4313236480 hasAuthorship W4313236480A5091546966 @default.
• W4313236480 hasAuthorship W4313236480A5091904917 @default.
• W4313236480 hasConcept C116567970 @default.
• W4313236480 hasConcept C11783203 @default.
• W4313236480 hasConcept C12174686 @default.
• W4313236480 hasConcept C126322002 @default.
• W4313236480 hasConcept C164705383 @default.
• W4313236480 hasConcept C201903717 @default.
• W4313236480 hasConcept C2778213512 @default.
• W4313236480 hasConcept C2779134260 @default.
• W4313236480 hasConcept C2908647359 @default.
• W4313236480 hasConcept C38652104 @default.
• W4313236480 hasConcept C41008148 @default.
• W4313236480 hasConcept C500558357 @default.
• W4313236480 hasConcept C60644358 @default.
• W4313236480 hasConcept C71924100 @default.
• W4313236480 hasConcept C72563966 @default.
• W4313236480 hasConcept C86803240 @default.
• W4313236480 hasConcept C99454951 @default.
• W4313236480 hasConceptScore W4313236480C116567970 @default.
• W4313236480 hasConceptScore W4313236480C11783203 @default.
• W4313236480 hasConceptScore W4313236480C12174686 @default.
• W4313236480 hasConceptScore W4313236480C126322002 @default.
• W4313236480 hasConceptScore W4313236480C164705383 @default.
• W4313236480 hasConceptScore W4313236480C201903717 @default.
• W4313236480 hasConceptScore W4313236480C2778213512 @default.
• W4313236480 hasConceptScore W4313236480C2779134260 @default.
• W4313236480 hasConceptScore W4313236480C2908647359 @default.
• W4313236480 hasConceptScore W4313236480C38652104 @default.
• W4313236480 hasConceptScore W4313236480C41008148 @default.
• W4313236480 hasConceptScore W4313236480C500558357 @default.
• W4313236480 hasConceptScore W4313236480C60644358 @default.
• W4313236480 hasConceptScore W4313236480C71924100 @default.
• W4313236480 hasConceptScore W4313236480C72563966 @default.

• next